Pharmacist’s Knowledge, Attitudes, Beliefs Influence Patients Receiving Vaccination
Drug Topics
APRIL 23, 2025
Investigators specifically analyze information on influenza and pneumococcal vaccinations.
Wed.Apr 23, 2025
476 
Full COVID-19 mRNA Vaccination Course Induces Long-Term Antibody, Memory B-Cell Response
Pharmacy Times
APRIL 23, 2025
New research highlights the long-lasting effectiveness of mRNA COVID-19 vaccines, showing sustained B-cell and antibody responses in health care workers over 3 years.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Hormonal Contraceptive Use Increases Risk of Depression
Drug Topics
APRIL 23, 2025
Researchers explored whether or not hormonal contraceptive initiation is associated with increased risk of developing depression within 12 months of child delivery.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 23, 2025
One of the biggest congressional battles this year will be an upcoming reconciliation bill, which could see the Medicaid program cut by hundreds of billions of dollars. Here's how that could impact the country's healthcare system.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Impact of Increased Drug Advertising on Patients, Consumers
Drug Topics
APRIL 23, 2025
Expert in drug markets, Luke Turnock, PhD, joined Drug Topics to assess where he thinks recent trends in drug advertising will lead patients in the near-to-long-term future.
Boehringer to expand oncology presence with $572m Tessellate Bio deal
Pharmaceutical Technology
APRIL 23, 2025
The agreement gives Boehringer access to Tessellates novel approach targeting ALT-dependent tumours.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Eli Lilly sues Mochi Health and others for ‘deceptive’ tirzepatide marketing
Pharmaceutical Technology
APRIL 23, 2025
The lawsuit filings are the latest turn in a long-running legal saga between GLP-1RAs makers and compounders.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 23, 2025
Blue Shield of California shared members' private health information with Google over a nearly three-year period, the insurance giant revealed earlier this month.
Axtria unveils transformational agentic AI platform for life sciences
pharmaphorum
APRIL 23, 2025
Axtria Inc., an AI-first data analytics innovator and global provider of cloud software to the life sciences industry, today announced its next generation of Axtria InsightsMAx, powered by agentic AI.
“We’ve Got to Get This Right From the Start”: Expert Discusses MDPNP Impacts on Pharmacies
Pharmacy Times
APRIL 23, 2025
Ronna Hauser, PharmD, senior vice president of policy and pharmacy affairs at NCPA, discussed concerns the association has with the implementation of the Medicare Drug Price Negotiation Plan
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Roche gets EU okay for chest pain algorithm
pharmaphorum
APRIL 23, 2025
Roche has claimed a CE Mark in the EU for an AI algorithm that can help doctors decide whether patients with chest pain are having a heart attack.
A Pharmacist’s Guide to Lung Cancer and Its Key Treatments
Pharmacy Times
APRIL 23, 2025
Though new treatments offer hope, careful monitoring and understanding of risks remain essential for their success.
Senior FDA resignations gut drug advertising function
pharmaphorum
APRIL 23, 2025
Two senior officials at the FDA's drug promotion office have resigned, leading to speculation that a clampdown on some advertising may be on the way.
Study: Antibiotic Allergy Delabeling Is Feasible and Safe With Few Adverse Events
Pharmacy Times
APRIL 23, 2025
The smartphone application-led delabeling also did not delay surgeries or procedures in the evaluated clinics.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal
pharmaphorum
APRIL 23, 2025
Cancer drug developer Veraxa Biotech has reached a deal to merge with a SPAC in a deal that will give it a Nasdaq listing and a $1.
Study: Mineral and Vitamin Levels in Pregnancy Linked to Midlife Blood Pressure
Pharmacy Times
APRIL 23, 2025
Research reveals that higher levels of vitamin B12, copper, and manganese during pregnancy lower midlife blood pressure and hypertension risk.
VOXO + PioneerRx: A Smarter Way to Manage Pharmacy Phone Calls
PioneerRx
APRIL 23, 2025
If theres anything certain in independent pharmacy, its this: the phones never stop ringing.
States Grant Prescribing Authority to Psychologists
Pharmacy Times
APRIL 23, 2025
This movement has aimed to address the mental health care epidemic in the United States.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
LogiPharma Europe 2025: Three Ways to Turn Sustainability Pledges Into Progress
Pharmaceutical Commerce
APRIL 23, 2025
Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares how stakeholders can drive meaningful, lasting impact by turning pledges into proof points, exercising patience, and embedding sustainability into core business operations.
First drug for rare disease APDS cleared for NHS use
pharmaphorum
APRIL 23, 2025
Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat APDS, an ultra-rare immunodeficiency disorder
ConcertAI and Bayer to boost precision oncology with AI and ML insights
Pharmaceutical Technology
APRIL 23, 2025
ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 23, 2025
New startup Superpower is jumping into the preventive health and longevity market offering personalized lab testing to give consumers more insights into their health.
TNF and Renova Health use AI to identify patients for GLP-1 treatments
Pharmaceutical Technology
APRIL 23, 2025
TNF and Renova Health are set to use AI and ML for the identification of high-risk subjects who could benefit from GLP-1 therapies
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 23, 2025
In an effort to decentralize pediatric sleep studies, Children's Hospital Los Angeles is leveraging a new app deployed on Apple Watch to collect more pediatric sleep data.
Has trial result burst BMS' Cobenfy bubble?
pharmaphorum
APRIL 23, 2025
Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 23, 2025
This week on "Podnosis," Yumlish CEO Shireen Abdullah joins us to discuss how culturally tailored nutrition education is helping tackle diabetesand why looming federal budget cuts could derail that progress.
Bad KOL data is expensive: Harnessing high-quality data for biopharma innovation
pharmaphorum
APRIL 23, 2025
As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data - and the costs of bad data - can help to avoid significant financial risks and missed opportunities.
Fierce Healthcare - Untitled Article
Fierce Healthcare
APRIL 23, 2025
Despite a slight decline in adjusted EBIDTA, the for-profit's CEO touted same-store volume gains and divestiture proceeds that are allowing it to reduce debt.
Making Real-World Evidence Work for Medicare: What CMS’ Draft Guidance Gets Right and What Needs Work
PharmExec
APRIL 23, 2025
CMS draft guidance on real-world data study protocols marks a significant move toward transparency and rigor in Medicare coverage decisions.
EditCo Bio secures access to Promega’s technologies in licensing deal
Pharmaceutical Technology
APRIL 23, 2025
EditCo Bio has entered a licensing agreement to secure access to Promegas protein-tagging and bioluminescent identification technologies.
Sebela’s Novel Potassium-Competitive Acid Blocker Demonstrates Promise in Gastroesophageal Reflux Disease
PharmExec
APRIL 23, 2025
Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in patients with erosive esophagitis and non-erosive reflux disease.
Synthetic hormones and the future of contraception
Pharmaceutical Technology
APRIL 23, 2025
Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing synthetic hormones.
Akeso’s PD-1/VEGF Bispecific Antibody Demonstrates Meaningful Progression-Free Survival Benefits in Advanced Squamous NSCLC
PharmExec
APRIL 23, 2025
In the Phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly outperformed tislelizumab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.
Let's personalize your content